C-reactive protein and cardiovascular disease: Weighing the evidence

被引:67
作者
Lowe G.D.O. [1 ]
Pepys M.B. [1 ]
机构
[1] Centre for Amyloidosis and Acute Phase Proteins, Department of Medicine, University College London, London NW3 2PF, Rowland Hill Street
基金
美国国家卫生研究院; 英国医学研究理事会; 英国惠康基金;
关键词
Arterioscler Thromb Vasc Biol; Coronary Heart Disease Event; Mendelian Randomization; Incident Coronary Heart Disease; Mendelian Randomization Study;
D O I
10.1007/s11883-006-0040-x
中图分类号
学科分类号
摘要
C-reactive protein (CRP) has been widely promoted as a strong, independent predictor of cardiovascular events and metabolic syndrome, both in general populations and in patients with clinical cardiovascular disease, and as a causal player in atherothrombosis. However, recent evidence shows that the association of CRP with cardiovascular events is weaker than previously thought, that it may be largely attributed to confounding by established causal risk factors, and that CRP is, therefore, probably not a clinically useful risk predictor. The lack of association of non-coding CRP gene polymorphisms (which determine different baseline CRP values) with coronary events or metabolic syndrome does not support a causal role for CRP, and most of the putatively proatherothrombotic in vitro effects claimed for CRP were caused by contaminants in commercial CRP preparations and not by CRP. Future clinical trials of specific CRP inhibitors now in development could directly test the contribution of CRP to pathogenesis of cardiovascular disease. Copyright © 2006 by Current Science Inc.
引用
收藏
页码:421 / 428
页数:7
相关论文
共 50 条
[21]  
Miller M., Zhan M., Havas S., High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors. The Third National Health and Nutrition Examination Survey, Arch Intern Med, 165, pp. 2063-2068, (2005)
[22]  
Ford E.S., The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: Findings from the Third National Health and Nutrition Examination Survey, Atherosclerosis, 168, pp. 351-358, (2003)
[23]  
Rumley A., Emberson J.R., Wannamethee S.G., Et al., Effects of older age on fibrin D-dimer, C-reactive protein, and other hemostatic and inflammatory variables in men aged 60-79 years, J Thromb Haemost, 4, pp. 982-987, (2006)
[24]  
Wannamethee S.G., Lowe G.D., Shaper A.G., Et al., Association between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease, Eur Heart J, 26, pp. 1765-1773, (2005)
[25]  
Wannamethee S.G., Lowe G.D., Shaper A.G., Et al., Insulin resistance, haemostatic and inflammatory markers and coronary heart disease risk factors in type 2 diabetic men with and without coronary heart disease, Diabetologia, 47, pp. 1557-1565, (2004)
[26]  
Wannamethee S.G., Lowe G.D., Whincup P.H., Et al., Physical activity and hemostatic and inflammatory variables in elderly men, Circulation, 105, pp. 1785-1790, (2002)
[27]  
Lawlor D.A., Davey Smith G., Rumley A., Et al., Associations of fibrinogen and C-reactive protein with prevalent and incident coronary heart disease are attenuated by adjustment for confounding factors. British Women's Heart and Health Study, Thromb Haemost, 93, pp. 955-963, (2005)
[28]  
O'Reilly D.S., Upton M.N., Caslake M.J., Et al., Midspan and WOSCOPS study groups: Plasma C reactive protein concentration indicates a direct relation between systemic inflammation and social deprivation, Heart, 92, pp. 533-535, (2006)
[29]  
Tzoulaki I., Murray G.D., Lee A.J., Et al., C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population. Edinburgh Artery Study, Circulation, 112, pp. 976-983, (2005)
[30]  
Greenfield J.R., Samaras K., Jenkins A.B., Et al., Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences, Circulation, 109, pp. 3022-3028, (2004)